Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: results of a sequential nonrandomized phase II study. Subcutaneous Administration Propeukin Program Cooperative Group.
暂无分享,去创建一个
C. Chastang | A. Monnier | Y. Chrétien | P. Guillet | J. Andrieu | V. Lucas | C. Pfister | B. Paule | A. Méjean | D. Hauteville | I. Krakowski | M. di Palma | J. Berdah | E. Malaurie | D. Mayeur | M. Untereiner | J. Tourani | A. Benhammouda | Y. Brewer | Z. Tadrist | P. Salze | D. Larregain-Fournier | J. Pavlovitch | M. Di Palma | M. Azagury | H. Abourachid